Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C

Cappellini, M.D. and Elalfy, M. and El-Beshlawy, A. and Kattamis, A. and Chan, L.L. and Li, C. and Lin, K.H. and Quarta, G. and Sutcharitchan, P. and Taher, A. and Habr, D. and Roubert, B. and Porter, J. (2010) Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C. Haematologica-The Hematology Journal, 95 (2). pp. 718-719.

Full text not available from this repository.
Item Type: Article
Additional Information: 15th Annual Meeting of the European-Hematology-Association, Barcelona, SPAIN, JUN 10-13, 2010
Subjects: R Medicine
Depositing User: Mr Faizal 2
Date Deposited: 20 Apr 2015 02:57
Last Modified: 20 Apr 2015 02:57
URI: http://eprints.um.edu.my/id/eprint/13338

Actions (login required)

View Item View Item